Pnc Financial Services Group, Inc. Rapt Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,020 shares of RAPT stock, worth $33,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,020
Previous 794
406.3%
Holding current value
$33,124
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$184 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$108 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$108 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$103 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$96.9 Million0.24% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $244M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...